Being told “you have high triglycerides” or “you have a fatty liver” raises two questions: is it serious and does it affect the heart? Often both findings point to elevated cardiometabolic risk that should be understood and corrected soon.
The most important
- High triglycerides and fatty liver are often associated with insulin resistance y metabolic syndrome, which increases cardiovascular risk.
- It's not just “fat on the liver”: the problem is the complete metabolism (glucose, blood pressure, weight, habits).
- Management combines sustainable lifestyle changes and, depending on the profile, medical treatment.
What are triglycerides?
Triglycerides (TG) are fats that circulate in the blood. They are raised by: excess sugars/refined flours, alcohol, sedentary lifestyle, abdominal weight gain, insulin resistance and some medications. More than a “fatty food”, they reflect a metabolic pattern sustained. To understand lipid targets review Cholesterol: the essentials y LDL: objectives and evaluation.
What is fatty liver?
It signifies accumulation of fat in the liver, linked to the fatty liver disease associated with metabolic dysfunction (MASLD). It usually coexists with high TG, elevated glucose, high blood pressure and increased waistline. It functions as early warning of energy mismanagement.
Three pathways of impact on the heart
- Risk markersHigh TG and fatty liver rarely come alone; they are combined with hypertension, high blood glucose and altered cholesterol. Consult Hypertension y Home pressure goals.
- Insulin resistancepromotes vascular inflammation and atherosclerosis. If you are already living with diabetes or prediabetes, check out Diabetes and heart: goals.
- Alterations of atherogenic cholesterolLDL and non-HDL cholesterol are usually the main targets for prevention.
Ranges that change urgency (mg/dL)
| TG | Interpretation |
|---|---|
| <150 | Normal |
| 150-199 | High limit |
| 200-499 | High |
| ≥500 | Very high (risk of pancreatitis + CV) |
Do not treat isolated TG: integrate the complete profile and the overall risk.
When to insist on valuation
Schedule an appointment if:
- TG ≥ 500 at any time.
- TG ≥ 200 persistent despite changes 4-8 wk.
- Fatty liver + other factor (high blood pressure, high glucose, abdominal obesity).
- Family history of early infarction/stroke.
- Symptoms such as shortness of breath, chest tightness or palpitations. See Lack of air, Chest pain y Palpitations.
Levers with greater impact
Feeding
- Eliminate sugary drinks and reduce refined flours.
- Limit alcohol (many TGs drop 20-30 % by removing it 4-6 wk).
- Increase lean protein, fiber and quality fats. Check out Cardioprotective nutrition.
Physical activity
Improves insulin sensitivity and lipid profile. Start safely with Heart-safe physical activity.
Abdominal weight
Losing 5-10 % of weight (when there is excess) usually reduces TG, hypertension and glucose.
Sleep and stress
Poor sleep quality and chronic stress worsen metabolic habits and profiles. See Stress, sleep and heart health.
Medical treatment
Decision based on global risk: sometimes LDL/non-HDL is prioritized first; other times, drugs for very high TGs. This is defined in cardiometabolic consultation.
What is included in a comprehensive assessment
- Complete lipid profile and calculation of non-HDL cholesterol.
- Glucose/HbA1c, blood pressure, BMI/waist.
- Review of medications/supplements.
- CV risk stratification (scores + history).
- Complementary tests according to the case: Electrocardiogram, Doppler echocardiogram o Cardiac check-up.
References
- American College of Cardiology. 2021 ACC Expert Consensus Decision Pathway on the Management of Hypertriglyceridemia (2021).
- AASLD. Clinical Practice Guidance on the Management of MASLD (2023).
- EASL-EASD-EASO. Clinical Practice Guidelines for metabolic dysfunction-associated steatotic liver disease (2024).